EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium (Q54454033)
scientific article
Language:
Current Data About EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
(P31) (Q13442814)
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P50) (Q39600160)
(P1545) 2
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q43779462)
(P1545) 4
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q39066258)
(P1545) 16
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q2346715)
(P1545) 14
(P1932) Jaap Goudsmit
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018

(Q59822898)
(P1545) 17
(P1932) Quentin Sattentau
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q88061163)
(P1545) 20
(P1932) Giuseppe Pantaleo
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q30004051)
(P1545) 15
(P1932) Mariano Esteban
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q57979852)
(P1545) 10
(P1932) Ralf Wagner
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q114406514)
(P1545) 9
(P1932) Marie-Joelle Frachette
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q55136644)
(P1545) 11
(P1932) Peter Liljeström
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q102056510)
(P1545) 1
(P1932) Pierre-Alexandre Bart
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q89421851)
(P1545) 3
(P1932) Tristan Barber
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q114406524)
(P1545) 12
(P1932) Jean-Pierre Kraehenbuhl
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(Q74229230)
(P1545) 19
(P1932) Abdel Babiker
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P304) 3153-3161
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P407) (Q1860)

(P433) 25
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P478) 26
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P577) Tuesday, May 27, 2008
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P921) (Q5452194)

(P1104) 9
(P887)

(P1433) (Q7907941)
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P1476) "EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium" (language: en)
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P2093) Ana Guimaraes-Walker
(P1545) 5
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

Mona Khonkarly
(P1545) 6
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

Neil C Sheppard
(P1545) 7
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

Yolanda Bangala
(P1545) 8
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

Marc Girard
(P1545) 13
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

Sheena McCormack
(P1545) 18
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

Jonathan Weber
(P1545) 21
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

EuroVacc Consortium
(P1545) 22
(P248)
(P698) 18502002
(P813) Wednesday, May 30, 2018
(P854) http://europepmc.org/abstract/MED/18502002

(P2860) (Q44138863)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.083
(P813) Thursday, January 7, 2021

(Q43000500)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.083
(P813) Thursday, January 7, 2021

(Q33827432)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.083
(P813) Thursday, January 7, 2021

(Q36022184)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.083
(P813) Thursday, January 7, 2021

(Q79776926)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.083
(P813) Thursday, January 7, 2021

other details
description scientific article

External Links
(P356) 10.1016/J.VACCINE.2008.03.083
(P698) 18502002